These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 8152308
1. Effect of the acute promyelocytic leukemia PML/RAR alpha protein on differentiation and survival of myeloid precursors. Fagioli M, Grignani F, Ferrucci PF, Alcalay M, Mencarelli A, Nicoletti I, Grignani F, Pelicci PG. Leukemia; 1994 Apr; 8 Suppl 1():S7-11. PubMed ID: 8152308 [Abstract] [Full Text] [Related]
2. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I. Cell; 1993 Aug 13; 74(3):423-31. PubMed ID: 8394219 [Abstract] [Full Text] [Related]
3. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Rousselot P, Hardas B, Patel A, Guidez F, Gäken J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F. Oncogene; 1994 Feb 13; 9(2):545-51. PubMed ID: 8290265 [Abstract] [Full Text] [Related]
4. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3. Testa U, Grignani F, Barberi T, Fagioli M, Masciulli R, Ferrucci PF, Seripa D, Camagna A, Alcalay M, Pelicci PG. Cancer Res; 1994 Aug 15; 54(16):4508-15. PubMed ID: 7519122 [Abstract] [Full Text] [Related]
5. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells. Grignani F, Testa U, Fagioli M, Barberi T, Masciulli R, Mariani G, Peschle C, Pelicci PG. Cancer Res; 1995 Jan 15; 55(2):440-3. PubMed ID: 7529139 [Abstract] [Full Text] [Related]
6. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E. Oncogene; 1995 Jun 15; 10(12):2307-14. PubMed ID: 7784078 [Abstract] [Full Text] [Related]
7. The molecular genetics of acute promyelocytic leukemia. Grignani F, Fagioli M, Ferrucci PF, Alcalay M, Pelicci PG. Blood Rev; 1993 Jun 15; 7(2):87-93. PubMed ID: 8396481 [Abstract] [Full Text] [Related]
8. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line. Nason-Burchenal K, Gandini D, Botto M, Allopenna J, Seale JR, Cross NC, Goldman JM, Dmitrovsky E, Pandolfi PP. Blood; 1996 Nov 15; 88(10):3926-36. PubMed ID: 8916959 [Abstract] [Full Text] [Related]
9. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling. Ruthardt M, Testa U, Nervi C, Ferrucci PF, Grignani F, Puccetti E, Grignani F, Peschle C, Pelicci PG. Mol Cell Biol; 1997 Aug 15; 17(8):4859-69. PubMed ID: 9234742 [Abstract] [Full Text] [Related]
10. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia. Grimwade D, Solomon E. Curr Top Microbiol Immunol; 1997 Aug 15; 220():81-112. PubMed ID: 9103677 [Abstract] [Full Text] [Related]
11. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies. Ruthardt M, Orleth A, Tomassoni L, Puccetti E, Riganelli D, Alcalay M, Mannucci R, Nicoletti I, Grignani F, Fagioli M, Pelicci PG. Oncogene; 1998 Apr 16; 16(15):1945-53. PubMed ID: 9591778 [Abstract] [Full Text] [Related]
12. The t(15;17) translocation in acute promyelocytic leukemia. Lavau C, Dejean A. Leukemia; 1994 Oct 16; 8(10):1615-21. PubMed ID: 7934155 [Abstract] [Full Text] [Related]
13. Acute promyelocytic leukemia: from clinic to molecular biology. Chen SJ, Wang ZY, Chen Z. Stem Cells; 1995 Jan 16; 13(1):22-31. PubMed ID: 7719245 [Abstract] [Full Text] [Related]
14. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha. Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP. Oncogene; 2006 Mar 23; 25(13):1974-9. PubMed ID: 16331271 [Abstract] [Full Text] [Related]
15. Acute promyelocytic leukaemia and the t(15;17) translocation. Gillard EF, Solomon E. Semin Cancer Biol; 1993 Dec 23; 4(6):359-67. PubMed ID: 8142621 [Abstract] [Full Text] [Related]
16. [Effects of PML and PML-RAR alpha antisense oligonucleotides on promyelocytic leukemia cell line NB4]. Chen Y, Miao J, Fang Z. Zhonghua Zhong Liu Za Zhi; 2000 Jul 23; 22(4):283-6. PubMed ID: 11778550 [Abstract] [Full Text] [Related]
17. The t(15;17) translocation in acute promyelocytic leukemia. Lavau C, Jansen J, Dejean A. Pathol Biol (Paris); 1995 Mar 23; 43(3):188-96. PubMed ID: 7675545 [Abstract] [Full Text] [Related]
18. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid. Mologni L, Marchesi E, Nielsen PE, Gambacorti-Passerini C. Cancer Res; 2001 Jul 15; 61(14):5468-73. PubMed ID: 11454693 [Abstract] [Full Text] [Related]
19. The molecular biology of acute promyelocytic leukemia. Slack JL, Gallagher RE. Cancer Treat Res; 1999 Jul 15; 99():75-124. PubMed ID: 9891864 [Abstract] [Full Text] [Related]
20. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS, Eastern Cooperative Oncology Group. Cytometry B Clin Cytom; 2004 May 15; 59(1):1-9. PubMed ID: 15108165 [Abstract] [Full Text] [Related] Page: [Next] [New Search]